Bioprocessing White Papers

  1. Biomanufacturing Readiness: A Validation Model For Multiproduct Facilities 6/12/2025

    Optimize your validation strategy to meet evolving regulatory demands and product complexities with a scalable, efficient framework that accelerates facility readiness and ensures consistent quality.

  2. Preclinical Evaluation Of Vaccines And Antivirals In RSV Challenge Rodent Models 6/10/2025

    Here, we present multiple case studies utilizing clinically relevant mouse and rat models to evaluate key characteristics of potential RSV therapeutics.

  3. Preclinical Evaluation Of New Antifibrotics In NASH-Induced Fibrosis Models 6/10/2025

    Accelerate the development of antifibrotic therapies through our clinically relevant models, deep scientific expertise, and proven preclinical capabilities in this area of unmet medical need.

  4. Preclinical Evaluation Of Antifibrotics In COVID-Induced Fibrosis Model 6/10/2025

    Advancing the development of effective antifibrotic therapies requires urgent investment in clinically relevant, IND-enabling preclinical models to address the growing burden of fibrotic diseases.

  5. Preclinical Evaluation Of Vaccines And Antivirals In RSV Challenge SCID Mouse Models 6/10/2025

    Advance your RSV therapeutic pipeline with trusted, IND-enabling preclinical services that deliver clinically relevant data through optimized study designs and validated rodent models.

  6. Preclinical Evaluation Of RSV Vaccines And Antivirals In BALB/c Mice 6/10/2025

    Accelerate your RSV therapeutic development with clinically relevant preclinical models and expert IND-enabling services that deliver the data needed to advance confidently toward clinical trials.

  7. Flow Chemistry Vs. Batch Processes 6/10/2025

    Explore how continuous flow chemistry can accelerate your chemical development with greater efficiency, safety, and sustainability compared to traditional batch processes.

  8. Analytical Techniques For Assessing Quality Of Therapeutic Proteins 6/5/2025

    Evaluating quality attributes of therapeutic proteins requires a strategic, regulation-compliant selection of analytical techniques that consider molecular characteristics and phase to ensure characterization.

  9. Streamline Your mAb Manufacturing With Strategic Development And CDMO Compatibility 6/4/2025

    Though the journey to mAb development begins at lab scale, for clinical trials and commercial distribution, a production process must be streamlined and scalable to 2,000 L production and above.

  10. Challenges, Methods, And Solutions For Obtaining Optimal Starting Material 6/3/2025

    For innovative treatments like CAR-T and stem cell transplants, optimal starting material is key. Understanding collection challenges and new solutions helps ensure the best foundation for these therapies.